SAZ Q1 2026 Earnings EPS Deeply Misses Estimates as Net Investment Income Turns Negative ATOS Q1 2026 Earnings Narrowing Loss Exceeds Expectations Amid Clinical Progress SYRE Q1 2026 Earnings WiderthanExpected Loss Highlights Development Stage Challenges NVS Q1 2026 Earnings EPS Misses Estimates by 85 Stock Declines Slightly PMTV Q1 2026 Earnings EPS Misses Estimates by 58 Stock Edges Higher Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development